GlaxoSmithKline Logo

GlaxoSmithKline BOOSTRIX Whooping Cough Ad Class Action Settlement

GlaxoSmithKline Logo
Open For Claims
No Proof

Adults vaccinated with BOOSTRIX in New York between May 20, 2016 and May 20, 2020 after viewing the Big Bad Cough advertising campaign.

Who’s Eligible

You may be eligible for the GlaxoSmithKline settlement if you:

Note: This eligibility applies to class members who meet the criteria below.

  • Are an adult who viewed one or more advertisements from GSK’s “Big Bad Cough” advertising campaign, which ran between 2015 and 2020
  • Lived in New York at the time of your vaccination, or received your BOOSTRIX vaccination in New York
  • Were vaccinated with BOOSTRIX (not a different Tdap brand) between May 20, 2016 and May 20, 2020
  • Received the BOOSTRIX vaccination in order to protect one or more other individuals from pertussis (whooping cough)

Eligible States

New York

Quick Eligibility Check

Answer a few quick questions below to see if you may qualify for this settlement.
Question 1 of 4

Claim Deadline

Last Day to Submit a Claim: 2026-06-08
Days
Hours
Minutes
Seconds

What You Need to Do to Get Paid

To get paid from the GlaxoSmithKline settlement:

Claim Online

  1. Visit the official settlement claim site and go to the online claim form.
  2. If you received a personalized notice with a Notice ID and Confirmation Code, enter those when prompted. If not, select the option to complete a general claim form.
  3. Fill out all required sections, including your contact information, vaccination details, and attestation statements.
  4. If you have Qualifying Proof of Vaccination (records from your provider, pharmacy, or insurer), attach it to receive $50. Without proof, you can still claim $10 by attestation alone.
  5. Select your preferred payment method: Venmo, Zelle, virtual prepaid card, or physical check.
  6. Submit your claim before the June 8, 2026 deadline.

Claim by Mail

  1. Download the claim form from the official settlement website, or request one by calling 1-833-978-4147.
  2. Complete all five sections of the form carefully.
  3. Include copies (not originals) of any Qualifying Proof of Vaccination if you are claiming $50.
  4. Mail the completed form to the Big Bad Cough Settlement administrator so it is postmarked no later than June 8, 2026.

$50 with Qualifying Proof of Vaccination (healthcare provider records, insurer records, or medical documentation created before Feb 10, 2025); $10 with Attestation of Vaccination only (sworn statement, no documentary proof required).

This link will direct you to the official settlement website — administered by Angeion Group

Settlement Payout

Estimated Payout Per Person

GlaxoSmithKline settlement payments are either $50 or $10 per claimant, depending on whether you provide proof of vaccination. Submit a Qualifying Proof of Vaccination (records from your doctor, pharmacy, or insurer dated before February 10, 2025) and you’ll receive $50. Submit the claim form with only an attestation and no supporting documents, and the payment is $10. Only one claim may be filed per class member. Payment can be issued via Venmo, Zelle, virtual prepaid card, or physical check. Payments won’t go out until after the Final Approval Hearing on July 2, 2026, and any appeals are resolved.

Background of the Lawsuit

Lead Plaintiff Lori DeCostanzo filed suit against GlaxoSmithKline plc and GlaxoSmithKline LLC in the United States District Court for the Eastern District of New York, case no. 2:21-cv-04869-NJC-AYS. The lawsuit claims that GSK’s “Big Bad Cough” advertising campaign, which ran from 2015 to 2020 and featured animated wolves in each ad, misled viewers about BOOSTRIX’s ability to prevent vaccinated individuals from transmitting pertussis (whooping cough) to others.

GSK has denied all allegations and maintains that BOOSTRIX remains FDA-approved for immunization against pertussis, tetanus, and diphtheria. GSK also notes that the plaintiff did not allege she contracted or transmitted pertussis, and that the advertising campaign accurately reflected CDC guidance in effect at the time. The plaintiff did not challenge the safety or effectiveness of BOOSTRIX for protecting the people who received the vaccine.

Neither side has won in court. GSK agreed to settle to avoid the cost and uncertainty of continued litigation. The settlement is not an admission of wrongdoing.

For more information, visit the Consumer Protection settlements hub or the official settlement website.

Frequently Asked Questions

Who is eligible for the GlaxoSmithKline BOOSTRIX settlement?
You may qualify if you are an adult who lived in New York or were vaccinated with BOOSTRIX in New York between May 20, 2016 and May 20, 2020, and got the vaccine to protect others after seeing the Big Bad Cough ads.
You can receive $50 if you submit qualifying proof of your BOOSTRIX vaccination, or $10 if you submit only an attestation without supporting documentation.
You must submit your claim online or postmark your paper claim form by June 8, 2026.
GlaxoSmithKline is settling claims that its Big Bad Cough advertising campaign misled viewers about BOOSTRIX’s ability to prevent vaccinated people from spreading whooping cough to others. GSK denied wrongdoing.
You don’t need proof to file, but it affects how much you receive. With qualifying vaccination records, you get $50. Without documentation, you can still claim $10 by attestation.
GlaxoSmithKline settlement rules accept records from your health care provider, pharmacy, or insurer, or other medical documentation created before February 10, 2025, that confirm your BOOSTRIX vaccination during the class period.
You can choose from Venmo, Zelle, a virtual prepaid card, or a physical check when you fill out your claim form.
You will not receive any payment and you will give up certain legal rights, including the right to sue GSK over the claims resolved by this settlement.

Settlement Administrator

Big Bad Cough Settlement
c/o Settlement Administrator
1650 Arch Street, Suite 2210
Philadelphia, PA 19103

For questions about claims, deadlines, or payments, contact the settlement administrator directly.

More Settlements

Explore other claims you may qualify for.

Case Details

Case Title: DeCostanzo v. GlaxoSmithKline plc et al.
Case Number: 2:21-cv-04869-NJC-AYS
Siri & Glimstad LLP

Listing Information

Published: April 28, 2026
Last Updated: April 28, 2026
Sources
Information verified against official court documents. Learn how we verify
Found an error? Let us know

No news articles related to this settlement yet

Discussion

Discuss or share information related to this settlement.

Disclaimer

The information on this website is free to access and provided for general educational and informational purposes only. It is not legal advice. We summarise settlement information from official notices, court documents, settlement websites, administrators, and other primary sources where available.

Settlement details and deadlines may change. Always refer to the official settlement website or consult a licensed attorney for advice specific to your situation.

Every listing is reviewed by our research team. Found an error? Let us know. Learn more about how we verify our information.

© TheClassActionLawsuit 2026